BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33360772)

  • 21. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
    Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
    Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
    Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
    Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.
    Schuhn A; Tobar TW; Gahlawat AW; Hauke J; Baumann L; Okun JG; Nees J
    Arch Gynecol Obstet; 2022 Nov; 306(5):1623-1632. PubMed ID: 35284957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease.
    Chang Y; Gao XQ; Shen N; He J; Fan X; Chen K; Lin XH; Li HM; Tian FS; Li H
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7433-7441. PubMed ID: 32706083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
    Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
    Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
    Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
    Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel serum metabolome score for breast cancer diagnosis.
    Rashed R; Darwish H; Omran M; Belal A; Zahran F
    Br J Biomed Sci; 2020 Oct; 77(4):196-201. PubMed ID: 32546046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis.
    Liu W; Ma J; Zhang J; Cao J; Hu X; Huang Y; Wang R; Wu J; Di W; Qian K; Yin X
    EMBO Mol Med; 2024 Apr; 16(4):988-1003. PubMed ID: 38355748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
    Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.
    Ihata Y; Miyagi E; Numazaki R; Muramatsu T; Imaizumi A; Yamamoto H; Yamakado M; Okamoto N; Hirahara F
    Int J Clin Oncol; 2014 Apr; 19(2):364-72. PubMed ID: 23700142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
    Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
    Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-High Performance Liquid Chromatography-Mass Spectrometry-based Serum Metabolomics for Early Diagnosis of Refractory Tumor-induced Osteomalacia: A Case-control Study.
    Li X; Gong Y; Zhang Q; Ni X; Pang Q; Chi Y; Jiajue R; Cui L; Jiang X; Wang O; Xing X; Jiang Y; Li M; Xia W
    J Clin Endocrinol Metab; 2023 Jul; 108(8):2016-2023. PubMed ID: 36718510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
    Torres A; Pac-Sosińska M; Wiktor K; Paszkowski T; Maciejewski R; Torres K
    BMC Cancer; 2019 Apr; 19(1):401. PubMed ID: 31035965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study.
    Deng L; Ismond K; Liu Z; Constable J; Wang H; Alatise OI; Weiser MR; Kingham TP; Chang D
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1283-1291. PubMed ID: 31151939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
    Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
    Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis.
    Qi SA; Wu Q; Chen Z; Zhang W; Zhou Y; Mao K; Li J; Li Y; Chen J; Huang Y; Huang Y
    Sci Rep; 2021 Jun; 11(1):11805. PubMed ID: 34083687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.